The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles

Biomaterials

Volumn 33, Issue 2, 2012, Pages 679-691

  Zhang, Yang ^a   Zhang, Hua ^a   Wang, Xueqing ^a   Wang, Jiancheng ^a   Zhang, Xuan ^a   Zhang, Qiang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Breast cancer; Cancer stem cells; Paclitaxel; Polymeric micelles; Salinomycin; Somatostatin receptors

Indexed keywords

BREAST CANCER; CANCER STEM CELLS; PACLITAXEL; POLYMERIC MICELLES; SALINOMYCIN; SOMATOSTATIN RECEPTORS;

CHEMOTHERAPY; DISEASES; ENCAPSULATION; ENZYME INHIBITION; MICELLES; MOLECULAR BIOLOGY; POLYMERS; STEM CELLS; TUMORS;

CYTOLOGY;

CD24 ANTIGEN; HERMES ANTIGEN; OCTREOTIDE; PACLITAXEL; POLYMER; SALINOMYCIN; SOMATOSTATIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CANCER STEM CELL; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG UPTAKE; ENDOCYTOSIS; FEMALE; FILM; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MICELLE; MOUSE; NONHUMAN; PARTICLE SIZE; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LACTONES; MICE; MICE, INBRED BALB C; MICE, NUDE; MICELLES; MICROSCOPY, CONFOCAL; NEOPLASTIC STEM CELLS; OCTREOTIDE; PACLITAXEL; POLYETHYLENE GLYCOLS; POLYMERS; PYRANS;

EID: 80055112766     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.09.072     Document Type: Article

References (44)

1. Vargo-Gogola T., Rosen J.M. Modeling breast cancer: one size does not fit all. Nat Rev Cancer 2007, 7(9):659-672.
2. Singla A.K., Garg A., Aggarwal D. Paclitaxel and its formulations. Int J Pharm 2002, 235:179-192.
3. Friedland D., Gorman G., Treat J. Hypersenstivity reactions from taxol and etoposide. J Natl Cancer Inst 1993, 85(24):2036.
4. Savic R., Luo L., Eisenberg A., Maysinger D. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 2003, 300(5619):615-618.
5. Forrest M.L., Won C.Y., Malick A.W., Kwon G.S. In vitro release of the mTOR inhibitor rapamycin from poly(ethylene glycol)-b-poly(e{open}-caprolactone) micelles. J Control Release 2006, 110(2):370-377.
6. Zhang Y., Zhuo R.X. Synthesis and in vitro drug release behavior of amphiphilic triblock copolymer nanoparticles based on poly(ethylene glycol) and polycaprolactone. Biomaterials 2005, 26(33):6736-6742.
7. Matsumura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986, 46:6387-6392.
8. Zeng F., Lee H., Allen C. Epidermal growth factor-conjugated poly(ethylene glycol)-block-poly(δ-valerolactone) copolymer micelles for targeted delivery of chemotherapeutics. Bioconjug Chem 2006, 17(2):399-409.
9. Mukhopadhyay S., Barnes C.M., Haskel A., Short S.M., Barnes K.R., Lippard S.J. Conjugated platinum(IV)-peptide complexes for targeting angiogenic tumor vasculature. Bioconjug Chem 2008, 19(1):39-49.
10. Gabizon A., Horowitz A.T., Goren D., Tzemach D., Shmeeda H., Zalipsky S. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice. Clin Cancer Res 2003, 9:6551-6559.
11. Lee E.S., Na K., Bae Y.H. Super pH-sensitive multifunctional polymeric micelle. Nano Lett 2005, 5:325-329.
12. Virgolini I., Leimer M., Handmaker H., Lastoria S., Bischof C., Muto P., et al. Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, 99mTc-P829. Cancer Res 1998, 58:1850-1859.
13. Corleto V.D., Nasoni S., Panzuto F., Cassetta S., Delle Fave G. Somatostatin receptor subtypes: basic pharmacology and tissue distribution. Dig Liver Dis 2004, 36:S8-S16.
14. Zhang J.L., Jin W., Wang X.Q., Wang J.C., Zhang X., Zhang Q. A novel octreotide modified lipid vesicle improved the anticancer efficacy of doxorubicin in somatostatin receptor 2 positive tumor models. Mol Pharmaceutics 2010, 7(4):1159-1168.
15. Hoelting T., Duh Q.Y., Clark O.H., Herfarth C. Somatostatin analog octreotide inhibits the growth of differentiated thyroid cancer cells in vitro, but not in vivo. J Clin Endocrinol Metab 1996, 81:2638-2641.
16. Li X.X., Lewis M.T., Huang J., Gutierrez C., Osborne C.K., Wu M.F., et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 2008, 100(9):672-679.
17. Yu F., Yao H., Zhu P., Zhang X., Pan Q., Gong C., et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007, 131(6):1109-1123.
18. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
19. Phillips T.M., McBride W.H., Pajonk F. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 2006, 98:1777-1785.
20. Dean M., Fojo T., Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005, 5:275-284.
21. Gupta P.B., Onder T.T., Jiang G., Tao K., Kuperwasser C., Weinberg R.A., et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009, 138:645-659.
22. Fuchs D., Daniel V., Sadeghi M., Opelz G., Naujokat C. Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells. Biochem Bioph Res Co 2010, 394:1098-1104.
23. Liu Y., Lu W.L., Guo J., Du J., Li T., Wu J.W., et al. A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes. J Control Release 2008, 129:18-25.
24. Gaucher G., Dufresne M.H., Sant V.P., Kang N., Maysinger D., Leroux J.C. Block copolymer micelles: preparation, characterization and application in drug delivery. J Control Release 2005, 109:169-188.
25. Dusi G., Gamba V. Liquid chromatography with ultraviolet of lasalocid, monensin, salinomycin and narasin in poultry feeds using pre-column derivatization. J Chromatogr A 1999, 835:243-246.
26. Lee J., Lee S.C., Acharya G., Chang C., Park K. Hydrotropic solubilization of paclitaxel: analysis of chemical structures for hydrotropic property. Pharm Res 2003, 20(7):1022-1030.
27. Hirschmann-Jax C., Foster A.E., Wulf G.G., Nuchtern J.G., Jax T.W., Gobel U., et al. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 2004, 101:14228-14233.
28. Zhou J., Wulfkuhle J., Zhang H., Gu P., Yang Y., Deng J., et al. Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci USA 2007, 104:16158-16163.
29. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003, 100:3983-3988.
30. Vichai V., Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc 2006, 1(3):112-1116.
31. Mamot C., Drummond D.C., Noble C.O., Kallab V., Guo Z., Hong K., et al. Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo. Cancer Res 2005, 65:11631-11638.
32. Riezman H., Woodman P.G., Van Meer G., Marsh M. Molecular mechanisms of endocytosis. Cell 1997, 91(6):731-738.
33. Allen T.M., Cheng W.W., Hare J.I., Laginha K.M. Pharmacokinetics and pharmacodynamics of lipidic nano-particles in cancer. Anticancer Agents Med Chem 2006, 6(6):513-523.
34. Zhan C., Gu B., Xie C., Li J., Liu Y., Lu W. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. J Control Release 2010, 143:136-142.
35. Wang Y.G., Yang T.Y., Wang X., Wang J.C., Zhang X., Zhang Q. Targeted polymeric micelle system for delivery of combretastatin A4 to tumor vasculature in vitro. Pharm Res 2010, 27:1861-1868.
36. Bae Y., Jang W.D., Nishiyama N., Fukushima S., Kataoka K. Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery. Mol BioSyst 2005, 1:242-250.
37. Torchilin V.P. Polymeric immunomicelles: carriers of choice for targeted delivery of water insoluble pharmaceuticals. J Drug Deliv Technol 2004, 4:251-261.
38. Goodell M.A., Brose K., Paradis G., Conner A.S., Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996, 183:1797-1806.
39. Kondo T., Setoguchi T., Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 2004, 101(3):781-786.
40. Ponti D., Costa A., Zaffaroni N., Pratesi G., Petrangolini G., Coradini D., et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005, 65:5506-5511.
41. Hashizume H., Baluk P., Morikawa S., McLean J.W., Thurston G., Roberge S., et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000, 156:363-1380.
42. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzym Regul 2001, 41:189-207.
43. Cortes J., Saura C. Nanoparticle albumin-bound (nab™)-paclitaxel: improving efficacy and tolerability by targeted drug delivery in metastatic breast cancer. Eur J Cancer 2010, 8(1):1-10.
44. Fukui M., Yamabe N., Zhu B.T. Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivo. Eur J Cancer 2010, 46(10):1882-1891.